Arabic Arabic English English French French German German
dark

Existing drug opens new possibilities for treating child leukemia

A new study from Linköping University has shown that the tumor-inhibiting gene TET2 is silenced in a large fraction of cases of acute lymphoblastic leukemia (ALL) in children. The scientists show that the gene can be reactivated by treatment with an existing drug, 5-azacytidine. The results, published in the scientific journal PNAS, suggest that 5-azacytidine may function as targeted therapy for ALL in children. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

ConcertAI, Janssen Partner to Address Health Disparities in Clinical Trials

Next Post

A diet consisting mainly of fruit is bad for you

Related Posts
Total
0
Share